In situ changes in the relative abundance of human epidermal cytokine messenger RNA levels following exposure to the poison ivy/oak contact allergen urushiol

Experimental Dermatology

Volumn 5, Issue 3, 1996, Pages 150-160

  Boehm, Keith D ^a,b   Yun, Jong K ^b   Strohl, Kingman P ^b   Trefzer, Uwe ^a   Häffner, Andreas ^a   Elmets, Craig A ^a,c  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

Allergic contact hypersensitivity; Interleukin 1 ; Interleukin 1 ; Keratinocyte; Poison ivy; Tumour necrosis factor

Indexed keywords

CYTOKINE; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; URUSHIOL;

ADULT; ARTICLE; CONTACT ALLERGY; CONTROLLED STUDY; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; NORMAL HUMAN; SKIN INFLAMMATION;

ADULT; CATECHOLS; CYTOKINES; DERMATITIS, TOXICODENDRON; EDEMA; ERYTHEMA; HUMANS; INTERLEUKIN-1; PLANTS, TOXIC; RNA, MESSENGER; SKIN; TIME FACTORS; TOXICODENDRON; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029984121     PISSN: 09066705     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0625.1996.tb00110.x     Document Type: Article

References (45)

1. Bergstresser P R. Immune mechanisms in contact allergic dermatitis. Dermatol Clinics 1990: 8: 3-11.
2. McMillan E M, Stoneking L, Burdick S, Cowan I, Husain-Hamzavi S L. Immunophenotype of lymphoid cells in positive patch tests of allergic contact dermatitis. J Invest Dermatol 1985: 84: 229-233.
3. Kalish R S, Johnson K L. Enrichment and function of urushiol (poison ivy)-specific T lymphocytes in lesions of allergic contact dermatitis to rushiol. J Immunol 1990: 145: 3706-3713.
4. Epstein W L. Allergic contact dermatitis to poison oak and ivy: feasibility of hyposensitization. Dermatol Clinics 1984: 2: 613-617.
5. Sunday M E, Dorf M E. Hapten-specific T cell response to 4-hydroxy-3-nitrophenyl acetyl X. Characterization of distinct T cell subsets mediating cutaneous sensitivity responses. J Immunol 1981: 127: 766-768.
6. Ptak W, Rozycka D, Askenase P W, Gershon R K. Role of antigen-presenting cells in the development and persistence of contact hypersensitivity. J Exp Med 1980: 151: 362-375.
7. Sullivan S, Bergstresser P R, Tigelaar R E, Streilein J W. Induction and regulation of contact hypersensitivity by resident, bone marrow-derived, dendritic epidermal cells: Langerhans cells and Thy-1+ epidermal cells. J Immunol 1986: 137: 2460-2467.
8. McKenzie R C, Sauder D N. The role of keratinocyte cytokines in inflammation and immunity. J Invest Dermatol 1990: 95: 105S-107S.
9. Camp R D R, Fincham N J, Ross J S, Bacon K B, Gearing A J H. Leukocyte chemoattractant cytokines of the epidermis. J Invest Dermatol 1990: 95: 108S-110S.
10. Barker J N W N, Mitra R S, Griffiths C E M, Dixit V M, Nickoloff B J. Keratinocytes as initiators of inflammation. Lancet 1991: 337: 211-214.
11. Griffiths C E M, Barker J N W N, Kunkel S, Nickoloff B J. Modulation of leukocyte adhesion molecules, a T-cell chemotaxin (IL-8) and a regulatory cytokine (TNF-α) in allergic contact dermatitis (Rhus dermatitis). Br J Dermatol 1991: 124: 519-526.
12. Piquet P F, Grau G E, Hauser C, Vassalli P. Tumor necrosis factor is a critical mediator in hapten-induced irritant and contact hypersensitivity reactions. J Exp Med 1991: 173: 673-679.
13. Enk A H, Katz S I. Early molecular events in the induction phase of contact hypersensitivity. Proc Natl Acad Sci USA 1992: 89: 1398-1402.
14. Bell T V, Harley C B, Stetsko D, Sauder D N. Expression of mRNA homologous to interleukin 1 in human epidermal cells. J Invest Dermatol 1987: 88: 375-379.
15. Kupper T S, Ballard D, Chua A O et al. Human keratinocytes contain mRNA indistinguishable from monocyte interleukin-1 alpha and beta mRNA. J Exp Med 1986: 169: 2095-2100.
16. Kock A, Schwarz T, Kirnbauer R et al. Human keratinocytes are a source for tumor necrosis factor alpha: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light. J Exp Med 1990: 172: 1609-1614.
17. Scala G, Oppenheim J J. Relationship of human interleukin 1 to antigen-presenting cell functions of a variety of human accessory cells. Lymphokine 1985: 12: 39-56.
18. Kimber I, Cumberbatch M. Stimulation of Langerhans cell migration by tumor necrosis factor α(TNF-α). J Invest Dermatol 1992: 92: 48S-50S.
19. Ansel J C, Perry P, Brown J et al. Cytokine modulation of keratinocyte cytokines. J Invest Dermatol 1990: 94: 101S-107S.
20. Jensen P K A, Jorgensen P, Thestrup-Pedersen K. Quantitative determination of IL-1α induced IL-8 mRNA levels in cultured human keratinocytes, dermal fibroblasts, endothelial cells, and monocytes. J Invest Derm 1991: 97: 506-510.
21. Griffiths C E, Voorhees J J, Nickoloff B J. Characterization of intercellular adhesion molecule-1 and HLA-DR expression in normal and inflamed skin: modulation by recombinant gamma interferon and tumor necrosis factor. J Am Acad Dermatol 1989: 20: 617-629.
22. Munro J M, Pober J S, Cotran R S. Tumor necrosis factor and interferon-gamma induce distinct patterns of endothelial activation and associated leukocyte accumulation in skin of Papio anubis. Am J Pathol 1989: 135: 121-133.
23. Nickoloff B J, Griffiths C E, Barker J N. The role of adhesion molecules, chemotactic factors, and cytokines in inflammatory and neoplastic skin disease - 1990 update. J Invest Dermatol 1990: 94: 151S-157S.
24. Barker J N, Sarma V, Mitra R, Dixit V M, Nickoloff B J. Marked synergism between tumor necrosis factor-aipha and interferon-gamma in regulation of keratinocyte-derived adhesion molecules and chemotactic factors. J Clin Invest 1990: 85: 605-608.
25. Fisher A A. Contact dermatitis, 3rd edition. Philadelphia: Lea & Febiger, 1986: 9-29.
26. Boehm K D, Kelly M F, Ilan J, Ilan J. The interleukin 2 gene is expressed in the syncytiotrophoblast of the human placenta. Proc Natl Acad Sci USA 1989: 86: 656-660.
27. March C J, Mosley B, Larsen A et al. Cloning, sequence and expression of two distinct human interluekin-1 complementary DNAs. Nature 1985: 315: 641-647.
28. Wang A M, Greasey A A, Ladner M B et al. Molecular cloning of the complementary DNA for human tumor necrosis factor. Science 1985: 228: 149-154.
29. Rigby W J, Dickmann M, Rhodes C, Berg P. Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase 1. J Molec Biol 1977: 113: 237-251.
30. Maxam A M, Gilbert W. Sequencing end-labeled DNA with base-specific chemical cleavages. Meth Enzymol 1980: 65: 499-560.
31. Turbitt M L, Akhurst R J, White S I, MacKie R. Localization of elevated transforming growth factor-α in psoriatic epidermis. J Invest Dermatol 1990: 95: 229-232.
32. Heufler C, Koch F, Schuler G. Granulocyte/macrophage colony-stimulating factor and interleukin-1 mediate the maturation of murine epidermal Langerhans cells into potent immunostimulator dendritic cells. J Exp Med 1988: 167: 700-705.
33. Sharpe R J, Margolis R J, Askari M, Amento E P, Granstein R D. Induction of dermal and subcutaneous inflammation by recombinant cachectin/tumor necrosis factor (TNF alpha) in the mouse. J Invest Dermatol 1988: 91: 353-357.
34. Gordon J R, Galli S J. Mast cells as a source of both preformed and immunologically inducible TNF-α/cachectin. Nature 1990: 346: 274-276.
35. Matsue H, Cruz P D Jr, Bergstresser P R, Takashima A. Langerhans cells are the major source of mRNA for IL-1β and MIP-1α among unstimulated mouse epidermal cells. J Invest Dermatol 1992: 92: 537-541.
36. Schreiber S, Kilgus O, Payer E et al. Cytokine pattern of Langerhans cells isolated from murine epidermal cell cultures. J Immunol 1992: 149: 3525-3534.
37. Gahring L C, Buckley A, Daynes R A. Presence of epidermal cell derived thymocyte activating factor/IL-1 in normal human stratum comeum. J Clin Invest 1985: 76: 1585-1594.
38. Hauser C, Saurat J H, Schmitt A, Jannin F, Dayer J M. Interleukin 1 is present in normal human epidermis. J Immunol 1986: 136: 3317-3323.
39. Didierjean L, Salomon D, Merot Y et al. Localization and characterization of the interleukin 1 immunoreactive pool (IL-1 α and β forms) in normal human epidermis. J Invest Dermatol 1989: 92: 809-816.
40. Trefzer U, Brockhaus M, Loetscher H et al. 55-kd tumor necrosis factor receptor is expressed by human keratinocytes and plays a pivotal role in regulation of human keratinocyte ICAM-1 expression. J Invest Dermatol 1991: 97: 911-916.
41. Beutler B, Milsark I W, Cerami A. Cachectin/tumor necrosis factor: production, distribution, and metabolic fate in vivo. J Immunol 1985: 135: 3972-3977.
42. Oxholm A, Oxholm P, Staberg B, Bendtzen K. Immunohistological detection of interleukin-1-like molecules and tumor necrosis factor in human epidermis before and after UVB-irradiation in vivo. Br J Dermatol 1988: 118: 369-376.
43. Beutler B, Krochin N, Milsark I W, Luedke C, Cerami A. Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. Science 1986: 232: 977-980.
44. Han J, Brown T, Beutler B. Endotoxin-responsive sequences control cachectin/tumor necrosis factor biosynthesis at the translational level. J Exp Med 1990: 171: 465-475.
45. Shakhov A, Collart M A, Vassalli P, Nedosparov S A, Jongeneel C V. kB-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor a gene in primary macrophages. J Exp Med 1990: 171: 35-47.